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We report that fructose 2,6-bisphosphate (Fru-2,6-Pz) levels in quiescent human fibroblasts timulated 
with insulin treatment increase in a time- and dose-dependent manner. The biochemical role of the sugar 
phosphate in the cellular esponse to the hormone which controls carbohydrate metabolism and acts as 
mitogenic factor is discussed. 
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1. INTRODUCTION 
Fru-2,6-Pz is a well-known sugar phosphate 
which has been demonstrated to be an important 
physiological regulator of carbohydrate metabo- 
lism and its concentration has been proved to be 
under hormonal regulation [ 11. 
by serum. In this connection it appears reasonable 
to investigate whether the polypeptide hormone 
added to resting fibroblasts can modify the in- 
tracellular concentration of Fru-2,6-Pz as has been 
reported for serum treatment. 
In [2] we showed the presence of Fru-2,6-Pz in 
human fibroblasts; its concentration increases in 
quiescent fibroblastic cells stimulated to pro- 
liferate by the addition of serum indicated it as be- 
ing the most potent growth-promoting factor. 
2. MATERIALS AND METHODS 
The concomitant stimulation of glycolysis and 
of phosphofructokinase (ATP : D-fructosed-phos- 
phate l-phosphotransferase, EC 2.7.1.11) (F6PK), 
one of the key enzymes of this metabolic pathway, 
was also observed as an early metabolic response 
induced by serum. 
Biochemicals and auxiliary enzymes for the 
assay of Fru-2,6-Pz and glucose were purchased 
from Boehringer Mannheim GmbH (Heidelberg). 
Bovine pancreas insulin and epidermal growth fac- 
tor (EGF) were obtained from Sigma (St Louis, 
MO). Fru-2,6-P2 was kindly provided by Dr E. 
van Schaftingen. For the cell cultures Eagle’s 
minimum essential medium (MEM), phosphate- 
buffered saline (PBS) and fetal calf serum (FCS) 
from Gibco were used. 
Among the many different factors which control 
the growth of mammalian cells, insulin is a well- 
known growth-promoting substance [3]. Although 
it is a poor mitogen, at least for mammalian cells, 
its role in cell division is far from negligible since 
insulin potentiates the effect of other growth fac- 
tors like EGF in a number of cell systems. 
2.1. Cell cultures 
Insulin has a marked effect on carbohydrate 
metabolism, which is evidenced by enhanced up- 
take of glucose [4], increased rate of glycolysis [4] 
and augmented activity of key glycolytic enzymes 
[5,6]; these are effects very similar to those elicited 
Human fibroblasts were obtained by biopsy 
from the forearm skin of normal subjects. Cell 
cultures were maintained in MEM supplemented 
with 10% FCS at 37°C in a humidified atmosphere 
of 95070 air, 5% COz. For the experiments about 
1.5 x lo5 cells were seeded in 60-mm petri dishes. 
At confluence the cultures were shifted to MEM- 
containing 1% FCS to induce the resting state. 
After 3 days of maintenance in serum-depleted 
medium, the monolayers were used for ex- 
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periments: the test substances were added in a 
small volume of aqueous 0.1% (w/v) solution of 
chicken ovalbumin to the cell cultures without 
changing the medium. At selected times the culture 
medium was collected and assayed for glucose con- 
tent [7]. 
2.2. Assay of Fru-2,6-PZ 
For the extraction of Fru-2,6-P2, monolayers 
were rapidly washed with PBS and 500~1 of hot 
50 mM NaOH were added directly to each dish. 
This extraction procedure gives higher values of 
Fru-2,6-P2 than those obtained with the previous 
method [2]. The extracts were quickly transferred 
to stoppered tubes and heated for 10 min at 80°C. 
Fru-2,6-Pz content of the extracts was assayed as in 
[8] based on the property of Fru-2,6-P2 to 
stimulate the pyrophosphate : fructosed-phos- 
phate 1-phosphotransferase (EC 2.7.1.90) (PPi- 
PFK) prepared from potato tubers [9]. The 
amounts of Fru-2,6-P2 were determined by com- 
paring the increase of PPi-PFK activity produced 
by cell extracts with that produced by known 
amounts of Fru-2,6-P2. The commercial fructose 
6-phosphate routinely used as substrate in the 
assay was acid-treated to destroy traces of con- 
taminant Fru-2,6-P2 [8]. Protein content was 
determined with the Coomassie blue method using 
bovine serum albumin as standard [lo]. 
Fig.1. Effect of 100 mM insulin addition on Fru-2,6-Pz 
content of human resting fibroblasts as a function of 
time. Controls received 0.1% (w/v) ovalbumin alone. 
Each value is the average of triplicate dishes. 
hormonal concentrations higher than 100 nM give 
no further increase in Fru-2,6-P2 content. In the 
same figure is reported the effect of the same range 
of concentrations of insulin on cellular glucose 
consumption. The resulting pattern indicates that, 
during the incubation period, the hormone is able 
The data are presented as means of values from 
triplicate assays in a representative xperiment. All 
observations have been repeated at least twice in 
separate experiments with different fibroblast 
strains. 
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3. RESULTS 
Human resting fibroblasts were incubated for 
different times and their Fru-2,6-Pz content was 
determined in the absence or presence of 100 nM 
insulin. The data reported in fig. 1 show that, upon 
exposure to insulin, a progressive increase of the 
intracellular content of the sugar phosphate was 
detected: after 7 h incubation an approx. 2-fold in- 
crease was observed. Fig.2 shows the dose- 
response curve for the insulin-induced increase of 
Fru-2,6-P2 content measured in quiescent fibro- 
blasts after 7 h exposure to the hormone: the half- 
maximal effect is obtained at about 6 nM insulin; 
Fig.2. Dose-response curve of Fru-2,6-Pz levels with 
varying concentrations of insulin in human resting 
fibroblasts. After the addition of insulin the cells were 
incubated for 7 h and then assayed for Fru-2,6-P2. At 
each point the collected medium was assayed for glucose 
content. Values shown are means f SE of experiments 
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Table 1 
Effect of insulin and EGF on Fru-2,6-F% content in 
human fibr~~~~sts 
Addition 
None 35 k 2 
Insulin (lo-’ M) 80 5 8 
Insulin (HP M) 73 k 7 
EGF (W M) 66&2 
insulin (IO-’ &I] g&s EGF 82 I s 
Insulin (HP M) plus EGF sy)+b 
Ex~riment~ conditions were the same as reported in 
fig.2 
The effect of EGF, another well-known growth- 
promoting factor on Fru-2,&Pz content, has been 
examined ulsing the same resting fibroblast$: the 
~pe~~t~l conditions and results are reported in 
table f _ EC%? (I +4) also ~~~~~~~~~ the ntra~e~~~~ 
concentration of sugar phosphate and an addi- 
tional increase is observed with both insuhn and 
EGF. 
The r~~ati~~s~p between lnsutin and Frr.&Z$-P~ 
levels in rot hepatocytes has been extensive@ in- 
vestigated [X1,12], and th@ hormonal effect ap- 
pears to be the result of counteracting the a&m of 
glucagon- So far nu evidence has ken reported un 
the eff~~ve~~ss of insulin by itself in ~~~~~~~g 
Fru-2,6-3% h~eIs. 
Our rest&s Indicate that insulin stirnu~~~~~~ of 
human resting fibrobl~ts It?u&~ to a clear iwrease 
in intracelluhrr Fru-2,6-P2 content. Moreover, the 
enh~~ern~~~ of sugar phosphate ~on~entr~~~~~ as 
an effect of insuhn treatment, is dose~e~~den~ 
from the dose-response curve it appears that 
physiola~~~~~ ~on~ntratio~s of insulin are ineffec- 
tive in raismg Fru-2,6-Pz Xevels, whereas mtimal 
mcrease is obtained with concentrations far in ex- 
cess of ph~~~lo~~ ones, 
On the ather hand, very high ins&n ~~~~~~tr~~ 
tions are required to stimuXate appreciably DNA 
synthesis in density inhibited fibroblasts F13,14T 
t~roM~h a number of molecuhrr events that are still 
largely unknown. The fact that high concentra- 
tions of insulin are required to elicit a significant 
increase either in Fru-2,6-PZ or in DNA synthesis 
murit not be underestimated: the irreffectiveness of 
p~~sjo~o~~~ on~e~~~atio~ of 5%3&r in exerting 
these biotogieal effects could be due to a signif& 
cant change in the physico-chemicd characteristics 
of insulin receptors in vitro as proposed in [15]+ 
Another interesting finding of this report is that 
the effect of EGF on Fru-2,633 content is similar 
to that produced hy ins&in and the a&on of in- 
sulin is partially ~d~tjve to that exwted by EGR 
the latter resuh may suggest a common mdeculnr 
rn~~~~isrn which controls sugar phosphate levels. 
In summary, our results show a novel cellular 
response to insulin action which at least accounts 
for the ~e~~-~b~~s~~d increase in ~~co~~~ fh3.x 
elicited by the hormone, likdy as a consequence of 
the positive moduhrtion of fibrobhrst F6PK by 
Fru-2,6-Pz. However, *ve are tempted to speculate 
that the enhancement of the sugar phosphate may 
represent a biochemical feature associated with eefl 
pro~~fe~tion~ this ~~po~~is is suppled by OCR 
recent research (31 preparation) that shows higher 
Fru-2,6-Pz levels in proliferating c&s compared 
with confluent ones without ~~imuIation of 
glyeolysis, 
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